Leadership Overview
Mars Veterinary has 5 executives leading key functions including finance, medical affairs, and veterinary operations.
Driven by a commitment to pet wellbeing, Mars Veterinary focuses on delivering exceptional veterinary care through innovation and a global network of dedicated professionals, enhancing the lives of pets and their owners worldwide.
Driven by a commitment to pet wellbeing, Mars Veterinary focuses on delivering exceptional veterinary care through innovation and a global network of dedicated professionals, enhancing the lives of pets and their owners worldwide.
Leadership Roles at Mars Veterinary
Jan Freudenberg - Chief Financial Officer
Jan Freudenberg, the Chief Financial Officer at Mars Veterinary, directs financial strategy and operations. Freudenberg oversees budgeting, forecasting, and financial reporting, ensuring fiscal health across the organization. This leadership role involves managing financial risks and identifying opportunities for profitable growth. By optimizing resource allocation, Jan Freudenberg supports the company's global expansion and commitment to high-quality veterinary care. The Chief Financial Officer's oversight extends to financial compliance and the implementation of robust internal controls, safeguarding the company's assets and stakeholder interests. Freudenberg's expertise is critical in navigating the complex financial landscape of the global veterinary health sector, aligning financial performance with the mission of improving pet wellbeing.
Edwin Stedem - Global Chief Financial Officer, Mars Veterinary Health
Edwin Stedem, the Global Chief Financial Officer, Mars Veterinary Health at Mars Veterinary, spearheads financial stewardship for the entire global veterinary health division. Stedem manages comprehensive financial planning, investment strategies, and capital allocation across thousands of clinics worldwide. This executive position involves driving financial performance and ensuring sustainable profitability to support the organization's ambitious growth objectives. By analyzing market trends and economic conditions, Edwin Stedem guides strategic financial decisions that enhance operational efficiency and veterinary care quality. The Global Chief Financial Officer's responsibilities include fostering strong relationships with financial institutions and stakeholders, ensuring transparency and accountability in all financial dealings. Stedem's leadership ensures the financial infrastructure effectively supports the mission of creating a better world for pets and their caregivers.

Tatsuhiko Miyamoto - Chief Financial Officer, At Vca (Japan)
Tatsuhiko Miyamoto, the Chief Financial Officer, At Vca (Japan) at Mars Veterinary, leads financial management for VCA's operations within Japan. Miyamoto is responsible for local financial planning, accounting, and compliance, ensuring adherence to both Japanese regulations and Mars Veterinary's global financial standards. This role focuses on optimizing financial performance within the specific market context of Japan, supporting the delivery of high-quality veterinary services. By managing local budgets and financial reporting, Tatsuhiko Miyamoto contributes to the strategic objectives of VCA in Japan. The Chief Financial Officer's oversight includes managing local financial teams and implementing financial controls to ensure operational integrity. Miyamoto's financial acumen is vital for the sustained success and growth of VCA's veterinary practices in the Japanese market.
Molly McAllister - Chief Medical Officer
Molly McAllister, the Chief Medical Officer at Mars Veterinary, directs the clinical vision and medical standards across the global network of veterinary hospitals. McAllister champions evidence-based medicine and oversees the implementation of best practices in animal healthcare, ensuring the highest quality of patient care. This critical role involves guiding clinical research initiatives and fostering a culture of continuous learning and professional development among veterinary professionals. By setting clinical protocols and evaluating new medical technologies, Molly McAllister enhances the effectiveness and safety of treatments. The Chief Medical Officer's influence extends to shaping the future of veterinary medicine, aligning medical strategies with the company's mission to improve pet wellbeing. McAllister's leadership ensures that Mars Veterinary remains at the forefront of medical innovation and compassionate care.

Todd Tams - Chief Medical Officer, External Affairs
Todd Tams, the Chief Medical Officer, External Affairs at Mars Veterinary, leads the organization's engagement with the broader veterinary community and external stakeholders. Tams focuses on building strategic partnerships and representing the company's medical expertise in external forums. This position involves communicating the company's commitment to advancing veterinary science and promoting professional collaboration. By managing external medical communications and initiatives, Todd Tams strengthens Mars Veterinary's reputation as a leader in animal health. The Chief Medical Officer, External Affairs, plays a key part in fostering relationships with professional organizations, academic institutions, and industry partners. Tams's efforts ensure that Mars Veterinary's medical insights and contributions are effectively shared, supporting the collective advancement of veterinary care globally.
Explore Leadership Teams in Business Services
Genentech, based in South San Francisco, California, is a biotechnology company specializing in the development of innovative therapies for serious medical conditions. Founded in 1976, Genentech serves the healthcare sector with a focus on research and development of biopharmaceuticals to improve patient outcomes.
Company Leadership AM
MP
BR
KT
CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites commitment to real world solutions.
Company Leadership
SC
TB
Natera is a global leader in cell-free DNA (cfDNA) testing, focused on advancing oncology, womens health, and organ health. The company aims to make personalized genetic testing and diagnostics part of the standard of care, helping protect health and enabling earlier, more targeted interventions that support longer, healthier lives.
Company Leadership
CO


Nuziveedu Seeds Limited (NSL) is a prominent seed company in India, recognized for its excellence in research and development. The company specializes in breeding programs that genetically enhance crops, ensuring substantial gains for farmers. With a commitment to quality and innovation, NSL operates state-of-the-art seed technology laboratories and has the largest seed processing and storage facilities in the country. NSL serves millions of farmers across South Asia, positioning itself as a trusted ally dedicated to improving agricultural productivity.
Company Leadership AS
SV
SA
KA